Sfoglia per Rivista ONCOIMMUNOLOGY
ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
2016-01-01 Zocchi, Maria Raffaella; Camodeca, Caterina; Nuti, Elisa; Rossello, Armando; Venè, Roberta; Tosetti, Francesca; Dapino, Irene; Costa, Delfina; Musso, Alessandra; Poggi, Alessandro
Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment
2016-01-01 Buglioni, S; Vici, P; Sergi, D; Pizzuti, L; Di Lauro, L; Antoniani, B; Sperati, F; Terrenato, I; Carosi, M; Gamucci, T; Vincenzoni, C; Mariani, L; Vizza, E; Venuti, A; Sanguineti, G; Gadducci, Angiolo; Barba, M; Natoli, C; Vitale, I; Mottolese, M; De Maria, R; Maugeri Saccà, M.
Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment
2016-01-01 Antonioli, Luca; Blandizzi, Corrado; Malavasi, Fabio; Ferrari, Davide; Haskó, György
Gc protein-derived macrophage-activating factor decreases alpha-N-acetylgalactosaminidase levels in advanced cancer patients
2013-01-01 L., Thyer; E., Ward; R., Smith; Branca, JACOPO JUNIO VALERIO; Morucci, Gabriele; Gulisano, Massimo; D., Noakes; R., Eslinger; Pacini, Stefania
IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients
2016-01-01 Tallerico, R; Cristiani, Cm; Staaf, E; Garofalo, C; Sottile, R; Capone, M; Pico de Coaña, Y; Madonna, G; Palella, E; Wolodarski, M; Carannante, V; Mallardo, D; Simeone, E; Grimaldi, Am; Johansson, S; Frumento, P; Gulletta, E; Anichini, A; Colucci, F; Ciliberto, G; Kiessling, R; Kärre, K; Ascierto, Pa; Carbone, E
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
2017-01-01 Brandetti, Elisa; Veneziani, Irene; Melaiu, Ombretta; Pezzolo, Annalisa; Castellano, Aurora; Boldrini, Renata; Ferretti, Elisa; Fruci, Doriana; Moretta, Lorenzo; Pistoia, Vito; Locatelli, Franco; Cifaldi, Loredana
Myeloid cells in the tumor microenvironment: Role of adenosine
2015-01-01 Morello, S; Pinto, A; Blandizzi, Corrado; Antonioli, Luca
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors
2018-01-01 Feola, S.; Capasso, C.; Fusciello, M.; Martins, B.; Tähtinen, S.; Medeot, M.; Carpi, S.; Frascaro, F.; Ylosmäki, E.; Peltonen, K.; Pastore, L.; Cerullo, V.
Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells
2018-01-01 Tosetti, Francesca; Venè, Roberta; Camodeca, Caterina; Nuti, Elisa; Rossello, Armando; D'Arrigo, Cristina; Galante, Denise; Ferrari, Nicoletta; Poggi, Alessandro; Zocchi, Maria Raffaella
T cell receptor-therapy in HBV-related hepatocellularcarcinoma.
2015-01-01 Bertoletti, A; Brunetto, MAURIZIA ROSSANA; Maini, Mk; Bonino, Ferruccio; Qasim, W; Stauss, H.
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors
2019-01-01 Boldrini, Renata; De Pasquale, Maria Debora; Melaiu, Ombretta; Chierici, Marco; Jurman, Giuseppe; Benedetti, Maria Chiara; Salfi, Nunzio C.; Castellano, Aurora; Collini, Paola; Furlanello, Cesare; Pistoia, Vito; Cifaldi, Loredana; Terenziani, Monica; Fruci, Doriana
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
2019-01-01 Moehler, M.; Heo, J.; Lee, H. C.; Tak, W. Y.; Chao, Y.; Paik, S. W.; Yim, H. J.; Byun, K. S.; Baron, A.; Ungerechts, G.; Jonker, D.; Ruo, L.; Cho, M.; Kaubisch, A.; Wege, H.; Merle, P.; Ebert, O.; Habersetzer, F.; Blanc, J. F.; Rosmorduc, O.; Lencioni, R.; Patt, R.; Leen, A. M.; Foerster, F.; Homerin, M.; Stojkowitz, N.; Lusky, M.; Limacher, J. M.; Hennequi, M.; Gaspar, N.; Mcfadden, B.; De Silva, N.; Shen, D.; Pelusio, A.; Kirn, D. H.; Breitbach, C. J.; Burke, J. M.
β3-adrenoreceptor and tumor microenvironment: a new hub
2015-01-01 Chiarugi, P.; Filippi, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing | 1-gen-2016 | Zocchi, Maria Raffaella; Camodeca, Caterina; Nuti, Elisa; Rossello, Armando; Venè, Roberta; Tosetti, Francesca; Dapino, Irene; Costa, Delfina; Musso, Alessandra; Poggi, Alessandro | |
| Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment | 1-gen-2016 | Buglioni, S; Vici, P; Sergi, D; Pizzuti, L; Di Lauro, L; Antoniani, B; Sperati, F; Terrenato, I; Carosi, M; Gamucci, T; Vincenzoni, C; Mariani, L; Vizza, E; Venuti, A; Sanguineti, G; Gadducci, Angiolo; Barba, M; Natoli, C; Vitale, I; Mottolese, M; De Maria, R; Maugeri Saccà, M. | |
| Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment | 1-gen-2016 | Antonioli, Luca; Blandizzi, Corrado; Malavasi, Fabio; Ferrari, Davide; Haskó, György | |
| Gc protein-derived macrophage-activating factor decreases alpha-N-acetylgalactosaminidase levels in advanced cancer patients | 1-gen-2013 | L., Thyer; E., Ward; R., Smith; Branca, JACOPO JUNIO VALERIO; Morucci, Gabriele; Gulisano, Massimo; D., Noakes; R., Eslinger; Pacini, Stefania | |
| IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients | 1-gen-2016 | Tallerico, R; Cristiani, Cm; Staaf, E; Garofalo, C; Sottile, R; Capone, M; Pico de Coaña, Y; Madonna, G; Palella, E; Wolodarski, M; Carannante, V; Mallardo, D; Simeone, E; Grimaldi, Am; Johansson, S; Frumento, P; Gulletta, E; Anichini, A; Colucci, F; Ciliberto, G; Kiessling, R; Kärre, K; Ascierto, Pa; Carbone, E | |
| MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma | 1-gen-2017 | Brandetti, Elisa; Veneziani, Irene; Melaiu, Ombretta; Pezzolo, Annalisa; Castellano, Aurora; Boldrini, Renata; Ferretti, Elisa; Fruci, Doriana; Moretta, Lorenzo; Pistoia, Vito; Locatelli, Franco; Cifaldi, Loredana | |
| Myeloid cells in the tumor microenvironment: Role of adenosine | 1-gen-2015 | Morello, S; Pinto, A; Blandizzi, Corrado; Antonioli, Luca | |
| Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors | 1-gen-2018 | Feola, S.; Capasso, C.; Fusciello, M.; Martins, B.; Tähtinen, S.; Medeot, M.; Carpi, S.; Frascaro, F.; Ylosmäki, E.; Peltonen, K.; Pastore, L.; Cerullo, V. | |
| Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells | 1-gen-2018 | Tosetti, Francesca; Venè, Roberta; Camodeca, Caterina; Nuti, Elisa; Rossello, Armando; D'Arrigo, Cristina; Galante, Denise; Ferrari, Nicoletta; Poggi, Alessandro; Zocchi, Maria Raffaella | |
| T cell receptor-therapy in HBV-related hepatocellularcarcinoma. | 1-gen-2015 | Bertoletti, A; Brunetto, MAURIZIA ROSSANA; Maini, Mk; Bonino, Ferruccio; Qasim, W; Stauss, H. | |
| Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors | 1-gen-2019 | Boldrini, Renata; De Pasquale, Maria Debora; Melaiu, Ombretta; Chierici, Marco; Jurman, Giuseppe; Benedetti, Maria Chiara; Salfi, Nunzio C.; Castellano, Aurora; Collini, Paola; Furlanello, Cesare; Pistoia, Vito; Cifaldi, Loredana; Terenziani, Monica; Fruci, Doriana | |
| Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE) | 1-gen-2019 | Moehler, M.; Heo, J.; Lee, H. C.; Tak, W. Y.; Chao, Y.; Paik, S. W.; Yim, H. J.; Byun, K. S.; Baron, A.; Ungerechts, G.; Jonker, D.; Ruo, L.; Cho, M.; Kaubisch, A.; Wege, H.; Merle, P.; Ebert, O.; Habersetzer, F.; Blanc, J. F.; Rosmorduc, O.; Lencioni, R.; Patt, R.; Leen, A. M.; Foerster, F.; Homerin, M.; Stojkowitz, N.; Lusky, M.; Limacher, J. M.; Hennequi, M.; Gaspar, N.; Mcfadden, B.; De Silva, N.; Shen, D.; Pelusio, A.; Kirn, D. H.; Breitbach, C. J.; Burke, J. M. | |
| β3-adrenoreceptor and tumor microenvironment: a new hub | 1-gen-2015 | Chiarugi, P.; Filippi, L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile